ASA Stock Recent News
ASA LATEST HEADLINES
Please see below information about transactions made under the first tranche of the 2025 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO).
Please see below information about transactions made under the first tranche of the 2025 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO).
OSLO, Norway , Feb. 25, 2025 /PRNewswire/ -- HydrogenPro ASA (OSE: HYPRO): HydrogenPro has today reported its financial results for the fourth quarter 2024. Achievements and highlights: - Q4 2024 revenues of NOK 70 million in Q4 2024, with 41% gross margin - ANDRITZ and MHI invested NOK 70 million, plus NOK70 million by LONGi (pending ODI approval) with 22% premium - New manufacturing line of advanced electrodes in Denmark in start-up, delivered on time and below budget.
OSLO, Norway , Feb. 25, 2025 /PRNewswire/ -- HydrogenPro ASA (OSE: HYPRO): HydrogenPro has today reported its financial results for the fourth quarter 2024. Achievements and highlights: Q4 2024 revenues of NOK 70 million in Q4 2024, with 41% gross margin ANDRITZ and MHI invested NOK 70 million, plus NOK70 million by LONGi (pending ODI approval) with 22% premium New manufacturing line of advanced electrodes in Denmark in start-up, delivered on time and below budget.
Oslo, 24 February 2025: Vow ASA (OSE: VOW) will release its report for the second half of 2024 on Thursday 27 February 2025 at 08:00 CET. The update will be published on https://newsweb.oslobors.no/ and on the company's web site www.vowasa.com.
The shares in Mowi ASA will be traded ex-dividend of NOK 2.00 as from today 21 February 2025. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
HBC will accelerate its manufacturing scale and market reach with the construction of a second enzymatic hydrolysis plant in Berkåk, Norway. Symrise will support the financing of the project through a EUR 5m loan. The partnership ideally complements both HBC and Symrise's current portfolio with science-led, clinically proven marine ingredients for Consumer Health. HBC have also signed an exclusive distribution agreement for OmeGo®, ProGo® and NT-II™ into the Consumer Health and Functional Food categories for four of Symrise's global key accounts.
Oslo, 20 February 2025: Vow ASA (OSE: VOW) subsidiary Scanship AS has won a EUR 3.4 million contract to provide equipment for a cruise ship retrofit in Europe.
Equinor ASA (OSE: EQNR, NYSE: EQNR) announced on 24 October 2024 an ordinary cash dividend per share of USD 0.35 and an extraordinary cash dividend per share of USD 0.35 for third quarter 2024.
OSLO, Norway , Feb. 19, 2025 /PRNewswire/ -- HydrogenPro ASA (OSE: HYPRO) will publish the financial results for the fourth quarter of 2024 on Tuesday 25 February 2025 at 07:00 CET. The company will host a webcast presentation of the results the same day at 10:00 CET, followed by a Q&A session.